journal article·2026-02

Water-soluble porphyrins derived from 5,10,15,20-tetrakis(N-ethylpyridinium-3-yl)porphyrin: Metal center effect on the photodynamic activity against aggressive triple-negative breast cancer lineage

Nathany Isabelly Dias Vieira, Pedro Fonseca-Pinheiro, Larissa Pereira Bento, Mariana de Oliveira Silva, Cláudio Eduardo Moreira de Souza, Renata Galvão de Lima, Renata Diniz, Gilson deFreitas-Silva, Elaine Maria de Souza-Fagundes, Dayse Carvalho da Silva Martins

Dyes and Pigments· Volume 245
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. IARC - marks breast cancer awareness month 2024
2. Exploring the potential of metallodrugs as chemotherapeutics for triple negative breast cancer10.1002/chem.202100438 ↗
3. Molecularly targeted therapies in breast cancer: a traditional review
4. Abordagem molecular no desenvolvimento de fármacos anti-tumorais
5. Photodynamic therapy of cancer: an update
6. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies10.3390/ijms25021023 ↗
7. Photodynamic therapy review: principles, photosensitizers, applications, and future directions10.3390/pharmaceutics13091332 ↗
8. Photodynamic therapy review: past, present, future, opportunities and challenges10.3390/photochem4040027 ↗
9. Hematoporphyrin as a photosensitizer of tumors10.1111/j.1751-1097.1983.tb02687.x ↗
10. Photodynamic therapy for the treatment and diagnosis of cancer–a Review of the current clinical status10.3389/fchem.2021.686303 ↗
11. Dye sensitizers for photodynamic therapy10.3390/ma6030817 ↗
12. Cancer, photodynamic therapy and porphyrin-type derivatives10.1590/0001-3765201820170811 ↗
13. Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD143310.1021/acs.chemrev.8b00211 ↗
14. A review of light sources and enhanced targeting for photodynamic therapy10.2174/0929867328666210121122106 ↗
15. Synthesis and antitumor activity of new porphyrin‐Platinum(II) complexes with the cytostatic platinum fragment attached to the porphyrin side chains10.1002/cber.1491271109 ↗
16. Platinum(II) complexes with porphyrin ligands—additive cytotoxic and photodynamic effect10.1002/anie.199422141 ↗
17. Uptake and light-induced cytotoxicity of hyaluronic acid-grafted liposomes containing porphyrin in tumor cells10.1016/j.jddst.2018.06.024 ↗
18. Benzamide porphyrins with directly conjugated and distal pyridyl or pyridinium groups substituted to the porphyrin macrocycles: study of the photosensitising abilities as inducers of apoptosis in cancer cells under photodynamic conditions10.1016/j.jphotobiol.2017.11.014 ↗
19. Combination of photodynamic therapy and gene silencing achieved through the hierarchical self-assembly of porphyrin-siRNA complexes10.1016/j.ijpharm.2019.118585 ↗
20. Brandon · 2019
21. Tetracationic porphyrin derivatives against human breast cancer10.1016/j.jphotobiol.2021.112258 ↗
22. Using porphyrins as albumin-binding molecules to enhance antitumor efficacies and reduce systemic toxicities of antimicrobial peptides10.1016/j.ejmech.2021.113382 ↗
23. Synthesis and biological properties of EGFR-targeted photosensitizer based on cationic porphyrin10.3390/pharmaceutics15041284 ↗
24. Synthesis and in vitro testing of hematoporphyrin type ligands in Platinum(II) complexes as potent cytostatic and phototoxic antitumor agents10.1016/S0020-1693(97)05593-X ↗
25. Double porphyrin platinum conjugates10.1515/znb-2002-0707 ↗
26. New porphyrin platinum conjugates for the cytostatic and photodynamic tumor therapy10.1016/S0020-1693(02)01490-1 ↗
27. Porphyrin platinum conjugates – new aims10.1016/S0020-1693(03)00479-1 ↗
28. Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells10.1021/bi049272v ↗
29. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF‐7 breast cancer cells by a C17α ‐alkynylestradiol‐porphyrin conjugate10.1002/jcb.20955 ↗
30. Low concentrations of a non-hydrolysable tetra-S-glycosylated porphyrin and low light induces apoptosis in human breast cancer cells via stress of the endoplasmic reticulum10.1039/b806536e ↗
31. Meso -Tetrakis(p -sulfonatophenyl)N-confused porphyrin tetrasodium salt: a potential sensitizer for photodynamic therapy10.1021/jm300009q ↗
32. Reactivity and stability of metalloporphyrin complex formation: DFT and experimental study10.3390/molecules25184221 ↗
33. Photodynamic therapy and the development of metal-based photosensitisers10.1155/2008/276109 ↗
34. Photodynamic therapy of inorganic complexes for the treatment of cancer10.1111/php.13467 ↗
35. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?10.1016/j.cbpa.2019.10.004 ↗
36. Structurally similar porphyrins and porphyrazines perform differently under green or red light irradiation against non-melanoma skin tumor cells10.1016/j.dyepig.2024.112527 ↗
37. Exploring structure–activity relationships in photodynamic therapy anticancer agents based on Ir(III)-COUPY conjugates10.1021/acs.jmedchem.3c00189 ↗
38. Recent advances in innovative strategies for enhanced cancer photodynamic therapy10.7150/thno.54227 ↗
39. Differential coordination demands in Fe versus Mn water-soluble cationic metalloporphyrins translate into remarkably different aqueous redox chemistry and biology10.1021/ic3012519 ↗
40. High lipophilicity of meta Mn(III) N-Alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli10.1021/jm900576g ↗
41. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins10.1039/c0dt01321h ↗
42. Relationship among redox potentials, proton dissociation constants of pyrrolic nitrogens, and in vivo and in vitro superoxide dismutating activities of manganese(III) and iron(III) water-soluble porphyrins10.1021/ic990118k ↗
43. Optimizing Zn porphyrin-based photosensitizers for efficient antibacterial photodynamic therapy10.1016/j.pdpdt.2016.11.009 ↗
44. Electron spin resonance spectroscopic and spectrophotometric investigation of the binding of tetracationic porphyrins and porphyrazines with calf thymus DNA. Unequivocal evidence for intercalation10.1039/f29858101739 ↗
45. Electronic spectra, resonance raman spectra and solution properties of water-soluble Cu(II), Ni(II) and Co(III) porphyrins10.1016/S0020-1693(00)83942-0 ↗
46. Analytical application of porphyrins—I spectrophotometric determination of ultramicro amounts of copper with α,β,γ,δ-tetra-(3-N-methylpyridyl)porphine10.1016/0039-9140(77)80122-7 ↗
47. Spectra of porphyrins10.1016/0022-2852(61)90236-3 ↗
48. Facile synthesis of water-soluble cationic Tin(IV) porphyrins and water-insoluble Tin(IV) porphyrins in water at ambient temperature10.1246/bcsj.20160091 ↗
49. The coordination chemistry of tin porphyrin complexes10.1016/j.ccr.2004.01.004 ↗
50. Synthesis and reactivity of porphyrin complexes of group IV p-elements10.1023/A:1020407029048 ↗
51. Optical spectra and electronic structure of porphyrins and related rings
52. Synthesis and hydrogen-bonded supramolecular assembly of trans-dihydroxotin(IV) tetrapyridylporphyrin complexes10.5012/bkcs.2004.25.12.1869 ↗
53. UV-vis absorption spectra of Sn(IV)tetrakis(4-pyridyl) porphyrins on the basis of axial ligation and pyridine protonation10.1007/s00894-019-4166-5 ↗
54. Redox chemistry of gold(III) porphyrins in water10.1039/f29868202337 ↗
55. Gold porphyrin complexes. Evidence for electrochemically inert gold (III)10.1016/S0020-1693(00)87273-4 ↗
56. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure10.1002/chem.200902741 ↗
57. Synthesis and cytotoxicity study of gold(III) porphyrin complexes and their derivative in breast cancer cells10.1016/j.jscs.2021.101366 ↗
58. Spectral properties and solution behavior of Gold(III) coordination compounds with water-soluble porphyrins10.1134/S0036023616120196 ↗
59. How does the tin(IV)-insertion to porphyrins proceed in water at ambient temperature?: Re-investigation by time dependent 1H NMR and detection of intermediates10.1016/j.ica.2018.07.036 ↗
60. 2014
61. The influence of lipophilicity in drug discovery and design10.1517/17460441.2012.714363 ↗
62. Amphiphilic cationic Zn-porphyrins with high photodynamic antimicrobial activity10.2217/fmb.14.148 ↗
63. Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn site10.3109/10715762.2010.522575 ↗
64. Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-Alkylpyridylporphyrins10.1074/jbc.M113.511642 ↗
65. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential10.1089/ars.2009.2876 ↗
66. Lipophilicity of potent porphyrin-based antioxidants: Comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins10.1016/j.freeradbiomed.2009.04.002 ↗
67. Luminescence of porphyrins and metalloporphyrins. Part 2.—Copper(II), chromium(III), manganese(III), iron(II) and iron(III) porphyrins10.1039/f19817700369 ↗
68. Dynamics of the exciplex formation and decay between excited CuTMpyP4+ and thymine C=O groups of short oligothymidylates
69. Luminescence of porphyrins and metalloporphyrins. Part 4.—Fluorescence of substituted tetraphenylporphyrins10.1039/F29817701695 ↗
70. Luminescence of porphyrins and metalloporphyrins. Part 3.—Heavy-atom effects10.1039/F29817701281 ↗
71. Photochemistry of water-soluble porphyrins: comparative study of isomeric tetrapyridyl- and tetrakis(N-methylpyridiniumyl)porphyrins10.1021/ic00184a019 ↗
72. Photochemistry of metalloporphyrins in aqueous solutions10.1016/0584-8539(89)80232-6 ↗
73. Lakowicz · 2006
74. Solvent dependent photophysical properties of free base tetrapyridylporphyrin10.1016/j.molliq.2014.11.001 ↗
75. Mechano-stimulus and environment-dependent circularly polarized TADF in chiral Copper(I) complexes and their application in OLEDs10.1021/jacs.2c09458 ↗
76. Balzani · 2014
77. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy10.1039/cs9952400019 ↗
78. Exploiting radical-pair intersystem crossing for maximizing singlet oxygen quantum yields in pure organic fluorescent photosensitizers10.1039/D0SC03128C ↗
79. Luminescence of porphyrins and metalloporphyrins. Part 1.—Zinc(II), nickel(II) and manganese(II) porphyrins10.1039/f19807601978 ↗
80. Photo-oxidation of metalloporphyrins in aqueous solution10.1039/f19837901335 ↗
81. Photophysical, electro- and spectroelectro-chemical properties of the nonplanar porphyrin [ZnOEP(Py)44+,4Cl-] in aqueous media10.1016/j.jphotochem.2010.04.019 ↗
82. Synthesis, photophysics, computational approaches, and biomolecule interactive studies of metalloporphyrins containing pyrenyl units: influence of the metal center
83. Two-stage ligand exchange in Mn(III)-based porphyrinic metal−organic frameworks for fluorescence water sensing10.1016/j.snb.2022.131808 ↗
84. Enhancing porphyrin photostability when locked in metal–organic frameworks10.1039/C8DT03638A ↗
85. An updated overview on the development of new photosensitizers for anticancer photodynamic therapy10.1016/j.apsb.2017.09.003 ↗
86. Terapia fotodinâmica: aspectos farmacológicos, aplicações e avanços recentes no desenvolvimento de medicamentos10.1590/S0100-40422002000500016 ↗
87. Human embryonic kidney 293 cells: a vehicle for biopharmaceutical manufacturing, structural biology and electrophysiology10.1159/000485501 ↗
88. Anticancer therapeutic potential of Mn porphyrin/ascorbate system10.1016/j.freeradbiomed.2015.10.416 ↗
89. An anticancer gold(III)-activated porphyrin scaffold that covalently modifies protein cysteine thiols10.1073/pnas.1915202117 ↗
90. Synergetic anticancer activity of gold porphyrin appended to phenyl tin malonate organometallic complexes10.1039/D0DT03792C ↗
91. Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes10.1080/13510002.2021.1917214 ↗
92. Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells
93. Studying the cellular distribution of highly phototoxic platinated metalloporphyrins using isotope labelling10.1039/D0CC05196A ↗
94. Phototoxicity: its mechanism and animal alternative test methods10.5487/TR.2015.31.2.097 ↗
95. Philips. PL-L Essential 36W/865/4P 1CT/50 - energy-saving compact fluorescent non-integrated lamphttps://www.lighting.philips.com/api/assets/v1/file/Signify/content/927933686503_EU.en_AA.PROF.FP/Localized_commercial_leaflet_927933686503_en_AA.pdf. [Accessed 23 August 2025].
96. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery10.1016/j.ejca.2004.01.009 ↗
97. Recent advances in therapeutic strategies for triple-negative breast cancer10.1186/s13045-022-01341-0 ↗
98. Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review10.3389/fonc.2023.1225694 ↗
99. Design and properties of porphyrin‐based singlet oxygen generator10.1002/ijch.201500026 ↗
100. Photosensitized oxidation of 2′,7′-dichlorofluorescin: singlet oxygen does not contribute to the formation of fluorescent oxidation product 2′,7′-dichlorofluorescein10.1016/S0891-5849(02)00982-6 ↗